GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | 10/30/2026 7:02:28 AM | Large | View | Financials | 10-Q | SEC | 3Q 2026 ending: 9/30/2026 | Rev: $5,115,800,000 +36.3% | Assets $44,405,200,000 | EPS $18.45 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 10/30/2026 6:51:26 AM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $5,115,800,000 +36.3% | Assets $44,405,200,000 | EPS $18.45 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 10/6/2026 7:52:14 AM | View | Financials | Earnings (Prelim) | SEC | 3Q 2026 | Export Earnings Model | ||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 7/30/2026 7:04:00 AM | Large | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $4,290,700,000 +16.7% | Assets $41,730,600,000 | EPS $12.23 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 7/30/2026 6:50:19 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $4,290,700,000 +16.7% | Assets $41,730,600,000 | EPS $12.23 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 7/6/2026 7:01:52 AM | View | Financials | Earnings (Prelim) | SEC | 2Q 2026 | Export Earnings Model | ||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/29/2026 7:04:09 AM | Large | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $3,605,400,000 +19.0% | Assets $40,868,800,000 | EPS $6.75 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/29/2026 6:50:40 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $3,605,400,000 +19.0% | Assets $40,868,800,000 | EPS $6.75 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/24/2026 4:05:48 PM | View | Proxy | SEC | Y 2025 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/8/2026 7:07:24 AM | View | Financials | Earnings (Prelim) | SEC | 1Q 2026 | Export Earnings Model | ||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/4/2026 9:11:49 AM | Large | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $14,342,900,000 +1.0% | Assets $40,558,700,000 | EPS $41.48 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 1/30/2026 6:52:03 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $3,884,300,000 +2.5% | Assets $40,558,700,000 | EPS $7.87 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 10/28/2025 7:04:31 AM | Large | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $3,754,300,000 +0.9% | Assets $40,169,400,000 | EPS $13.62 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 10/28/2025 6:51:19 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $3,754,300,000 +0.9% | Assets $40,169,400,000 | EPS $13.62 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 10/6/2025 7:02:16 AM | View | Financials | Earnings (Prelim) | SEC | 3Q 2025 | Export Earnings Model | ||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/1/2025 7:05:57 AM | Large | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $3,675,600,000 +3.6% | Assets $38,219,200,000 | EPS $12.81 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/1/2025 6:51:08 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $3,675,600,000 +3.6% | Assets $38,219,200,000 | EPS $12.81 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/29/2025 7:04:10 AM | Large | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $3,028,700,000 -3.7% | Assets $37,545,200,000 | EPS $7.27 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/29/2025 6:38:35 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $3,028,700,000 -3.7% | Assets $37,545,200,000 | EPS $7.27 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/29/2025 6:07:44 AM | View | Proxy | SEC | Y 2024 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/5/2025 9:24:13 AM | Large | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $14,202,000,000 +8.3% | Assets $37,759,400,000 | EPS $38.34 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/4/2025 7:12:33 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $3,789,200,000 +10.3% | Assets $37,759,400,000 | EPS $8.11 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 1/13/2025 7:23:42 AM | View | Financials | Earnings (Prelim) | SEC | Y 2024 | Export Earnings Model | ||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 10/31/2024 7:32:16 AM | Large | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $3,720,700,000 +10.6% | Assets $37,441,900,000 | EPS $11.54 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 10/31/2024 7:12:10 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $3,720,700,000 +10.6% | Assets $37,441,900,000 | EPS $11.54 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 10/7/2024 7:01:35 AM | View | Financials | Earnings (Prelim) | SEC | 3Q 2024 | Export Earnings Model | ||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/1/2024 7:30:03 AM | Large | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $3,547,100,000 +12.3% | Assets $36,086,800,000 | EPS $12.41 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/1/2024 7:07:35 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $3,547,100,000 +12.3% | Assets $36,086,800,000 | EPS $12.41 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 7/8/2024 7:01:41 AM | View | Financials | Earnings (Prelim) | SEC | 2Q 2024 | Export Earnings Model | ||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 5/2/2024 7:27:16 AM | Large | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $3,145,000,000 -0.5% | Assets $34,369,600,000 | EPS $6.27 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 5/2/2024 7:07:57 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $3,145,000,000 -0.5% | Assets $34,369,600,000 | EPS $6.27 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/25/2024 4:05:18 PM | View | Proxy | SEC | Y 2023 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/5/2024 9:27:40 AM | Large | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $13,117,200,000 +7.8% | Assets $33,080,200,000 | EPS $34.77 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/2/2024 7:17:19 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $3,434,300,000 +0.6% | Assets $33,080,200,000 | EPS $10.20 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 1/8/2024 6:32:31 AM | View | Presentation | SEC | Y 2024 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 11/2/2023 7:36:15 AM | Large | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $3,362,700,000 +14.5% | Assets $32,163,300,000 | EPS $8.89 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 11/2/2023 7:11:09 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $3,362,700,000 +14.5% | Assets $32,163,300,000 | EPS $8.89 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/3/2023 7:05:11 AM | Large | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $3,158,100,000 +10.5% | Assets $30,657,500,000 | EPS $8.50 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/3/2023 6:50:02 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $3,158,100,000 +10.5% | Assets $30,657,500,000 | EPS $8.50 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 5/4/2023 7:32:09 AM | Large | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $3,162,100,000 +6.6% | Assets $30,059,900,000 | EPS $7.17 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 5/4/2023 7:14:01 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $3,162,100,000 +6.6% | Assets $30,059,900,000 | EPS $7.17 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/21/2023 4:04:54 PM | View | Proxy | SEC | Y 2022 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/10/2023 7:02:37 AM | View | Financials | Earnings (Prelim) | SEC | 1Q 2023 | Export Earnings Model | ||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/6/2023 9:37:02 AM | Large | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $12,172,900,000 -24.3% | Assets $29,214,500,000 | EPS $38.22 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/3/2023 7:08:17 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $3,414,400,000 -31.0% | Assets $29,214,500,000 | EPS $10.49 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 1/9/2023 8:50:20 AM | View | Presentation | SEC | Y 2023 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 11/3/2022 7:36:59 AM | Large | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $2,936,200,000 -15.0% | Assets $27,677,800,000 | EPS $11.66 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 11/3/2022 7:20:38 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $2,936,200,000 -15.0% | Assets $27,677,800,000 | EPS $11.66 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/3/2022 7:39:01 AM | Large | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $2,857,200,000 -44.4% | Assets $27,205,800,000 | EPS $7.47 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/3/2022 7:09:26 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $2,857,200,000 -44.4% | Assets $27,205,800,000 | EPS $7.47 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 5/4/2022 7:28:09 AM | Large | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $2,965,100,000 +17.3% | Assets $26,348,700,000 | EPS $8.61 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 5/4/2022 7:14:05 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $2,965,100,000 +17.3% | Assets $26,348,700,000 | EPS $8.61 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/21/2022 4:12:22 PM | View | Proxy | SEC | Y 2021 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/7/2022 9:36:12 AM | Large | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $16,071,700,000 +89.1% | Assets $25,434,800,000 | EPS $71.97 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/4/2022 7:30:55 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $4,951,700,000 +104.4% | Assets $25,434,800,000 | EPS $19.68 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 1/10/2022 6:04:39 AM | View | Presentation | SEC | Y 2022 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 11/4/2021 7:35:11 AM | Large | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $3,452,800,000 +50.5% | Assets $23,671,500,000 | EPS $14.33 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 11/4/2021 7:13:34 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $3,452,800,000 +50.5% | Assets $23,671,500,000 | EPS $14.33 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/5/2021 7:22:30 AM | Large | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $5,138,500,000 +163.2% | Assets $21,485,900,000 | EPS $27.97 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/5/2021 7:00:15 AM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $5,138,500,000 +163.2% | Assets $21,485,900,000 | EPS $27.97 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 5/6/2021 7:32:18 AM | Large | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $2,528,700,000 +38.3% | Assets $17,772,200,000 | EPS $10.09 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 5/6/2021 7:13:19 AM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $2,528,700,000 +38.3% | Assets $17,772,200,000 | EPS $10.09 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/23/2021 4:13:28 PM | View | Proxy | SEC | Y 2020 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/8/2021 9:26:18 AM | Large | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $8,497,100,000 +29.6% | Assets $17,163,300,000 | EPS $30.52 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/5/2021 7:35:50 AM | View | Financials | Earnings | SEC | Y 2020 | Rev $2,422,900,000 +30.0% | Assets $17,163,300,000 | EPS $10.24 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 1/11/2021 6:05:25 AM | View | Presentation | SEC | Y 2021 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 11/5/2020 7:54:30 AM | Large | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $2,294,000,000 +31.6% | Assets $16,084,000,000 | EPS $7.39 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 11/5/2020 7:34:08 AM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $2,294,000,000 +31.6% | Assets $16,084,000,000 | EPS $7.39 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/5/2020 7:44:14 AM | Large | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $1,952,000,000 +23.7% | Assets $14,428,700,000 | EPS $7.61 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/5/2020 7:16:07 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $1,952,000,000 +23.7% | Assets $14,428,700,000 | EPS $7.61 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 5/5/2020 8:04:04 AM | Large | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $1,828,200,000 +33.2% | Assets $15,757,500,000 | EPS $5.43 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 5/5/2020 7:35:59 AM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $1,828,200,000 +33.2% | Assets $15,757,500,000 | EPS $5.43 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 4/24/2020 4:09:33 PM | View | Proxy | SEC | Y 2019 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/7/2020 10:22:23 AM | Large | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $6,557,600,000 +27.4% | Assets $14,805,200,000 | EPS $18.46 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 2/6/2020 7:35:13 AM | View | Financials | Earnings | SEC | Y 2019 | Rev $1,863,500,000 -3.3% | Assets $14,805,200,000 | EPS $6.93 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 1/13/2020 9:16:36 AM | View | Presentation | SEC | Y 2020 | ||||||
| REGENERON PHARMACEUTICALS, INC. (REGN) | 11/5/2019 8:50:00 AM | Large | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $1,743,700,000 +4.8% | Assets $13,939,300,000 | EPS $5.86 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 11/5/2019 7:37:08 AM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $1,743,700,000 +4.8% | Assets $13,939,300,000 | EPS $5.86 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/6/2019 8:08:59 AM | Large | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $1,577,800,000 -1.9% | Assets $13,173,600,000 | EPS $1.68 | |
| REGENERON PHARMACEUTICALS, INC. (REGN) | 8/6/2019 7:36:30 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $1,577,800,000 -1.9% | Assets $13,173,600,000 | EPS $1.68 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/7/2019 8:13:38 AM | Large | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $1,372,600,000 -9.2% | Assets $12,854,800,000 | EPS $3.99 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/7/2019 7:36:57 AM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $1,372,600,000 -9.2% | Assets $12,854,800,000 | EPS $3.99 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 4/26/2019 4:07:14 PM | View | Proxy | SEC | Y 2018 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 2/7/2019 5:10:34 PM | Large | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $5,145,600,000 -12.4% | Assets $11,734,500,000 | EPS $21.29 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 2/6/2019 7:49:06 AM | View | Financials | Earnings | SEC | Y 2018 | Rev $1,927,800,000 +21.8% | Assets $11,734,500,000 | EPS $7.15 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 11/6/2018 8:06:03 AM | Large | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $1,663,500,000 +10.8% | Assets $10,805,613,000 | EPS $5.17 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 11/6/2018 7:41:02 AM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $1,663,500,000 +10.8% | Assets $10,805,613,000 | EPS $5.17 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/2/2018 5:16:27 PM | Large | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $1,608,000,000 +9.4% | Assets $9,951,980,000 | EPS $4.82 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/2/2018 7:41:58 AM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $1,608,000,000 +9.4% | Assets $9,951,980,000 | EPS $4.82 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/3/2018 4:27:43 PM | Large | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $1,511,500,000 +14.6% | Assets $9,372,696,000 | EPS $4.16 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/3/2018 7:54:35 AM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $1,511,500,000 +14.6% | Assets $9,372,696,000 | EPS $4.16 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 4/23/2018 4:47:30 PM | View | Proxy | SEC | Y 2017 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 2/8/2018 4:35:01 PM | Large | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $5,872,200,000 +20.8% | Assets $8,764,300,000 | EPS $10.34 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 2/8/2018 7:37:17 AM | View | Financials | Earnings | SEC | Y 2017 | Rev $1,582,400,000 +29.0% | Assets $8,764,300,000 | EPS $1.50 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 1/8/2018 6:56:27 AM | View | Presentation | SEC | Y 2018 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 11/8/2017 8:11:02 AM | Large | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $1,500,700,000 +23.0% | Assets $8,701,215,000 | EPS $3.32 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 11/8/2017 7:46:55 AM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $1,500,700,000 +23.0% | Assets $8,701,215,000 | EPS $3.32 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/3/2017 7:52:52 AM | Large | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $1,470,100,000 +21.2% | Assets $8,106,373,000 | EPS $3.34 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/3/2017 7:29:25 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $1,470,100,000 +21.2% | Assets $8,106,373,000 | EPS $3.34 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/4/2017 7:52:52 AM | Large | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $1,318,991,000 +9.8% | Assets $7,817,365,000 | EPS $2.16 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/4/2017 7:23:33 AM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $1,318,991,000 +9.8% | Assets $7,817,365,000 | EPS $2.16 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 4/25/2017 6:06:08 AM | View | Proxy | SEC | Y 2016 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 2/9/2017 4:05:36 PM | Large | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $4,860,400,000 +18.4% | Assets $6,973,466,000 | EPS $7.70 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 2/9/2017 7:16:39 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $1,226,800,000 +11.7% | Assets $6,973,466,000 | EPS $2.19 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 1/9/2017 5:21:10 PM | View | Presentation | SEC | 1Q 2017 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 11/4/2016 7:32:27 AM | Large | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $1,220,122,000 +7.3% | Assets $6,828,019,000 | EPS $2.27 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 11/4/2016 7:13:50 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $1,220,122,000 +7.3% | Assets $6,828,019,000 | EPS $2.27 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/4/2016 7:31:35 AM | Large | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $1,212,629,000 +21.4% | Assets $6,204,906,000 | EPS $1.69 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/4/2016 7:19:41 AM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $1,212,629,000 +21.4% | Assets $6,204,906,000 | EPS $1.69 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/5/2016 7:35:22 AM | Large | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $1,200,849,000 +38.1% | Assets $5,904,460,000 | EPS $1.59 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/5/2016 7:16:05 AM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $1,200,849,000 +38.1% | Assets $5,904,460,000 | EPS $1.59 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 4/26/2016 4:19:41 PM | View | Proxy | SEC | Y 2015 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 2/11/2016 4:45:24 PM | Large | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $4,103,728,000 +45.5% | Assets $5,609,132,000 | EPS $5.52 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 2/9/2016 7:32:31 AM | View | Financials | Earnings | SEC | Y 2015 | Rev $1,098,077,000 +36.9% | Assets $5,609,132,000 | EPS $1.34 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 1/12/2016 6:01:01 AM | View | Presentation | SEC | 1Q 2016 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 11/4/2015 7:24:05 AM | Large | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $1,137,422,000 +56.7% | Assets $5,182,915,000 | EPS $1.82 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 11/4/2015 7:05:02 AM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $1,137,422,000 +56.7% | Assets $5,182,915,000 | EPS $1.82 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/4/2015 7:21:24 AM | Large | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $998,617,000 +50.0% | Assets $4,526,970,000 | EPS $1.69 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/4/2015 7:10:02 AM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $998,617,000 +50.0% | Assets $4,526,970,000 | EPS $1.69 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/7/2015 7:30:44 AM | Large | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $869,612,000 +39.0% | Assets $4,198,573,000 | EPS $0.66 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/7/2015 7:15:32 AM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $869,612,000 +39.0% | Assets $4,198,573,000 | EPS $0.66 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 4/21/2015 4:27:52 PM | View | Proxy | SEC | Y 2014 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 2/12/2015 4:39:16 PM | Large | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $2,819,557,000 +34.0% | Assets $3,837,672,000 | EPS $2.98 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 2/10/2015 7:31:35 AM | View | Financials | Earnings | SEC | Y 2014 | Rev $802,329,000 +31.4% | Assets $3,837,672,000 | EPS $0.78 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 1/13/2015 1:31:08 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $802,329,000 +31.4% | Assets $3,837,672,000 | EPS $0.78 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 11/4/2014 7:06:24 AM | Large | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $725,788,000 +21.6% | Assets $3,739,419,000 | EPS $0.73 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 11/4/2014 6:55:13 AM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $725,788,000 +21.6% | Assets $3,739,419,000 | EPS $0.73 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/5/2014 6:52:44 AM | Large | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $665,700,000 +45.5% | Assets $3,456,078,000 | EPS $0.85 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/5/2014 6:45:10 AM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $665,700,000 +45.5% | Assets $3,456,078,000 | EPS $0.85 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/8/2014 6:57:11 AM | Large | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $625,740,000 +42.3% | Assets $3,260,396,000 | EPS $0.61 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/8/2014 6:50:07 AM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $625,740,000 +42.3% | Assets $3,260,396,000 | EPS $0.61 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 4/24/2014 4:26:37 PM | View | Proxy | SEC | Y 2013 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 2/13/2014 4:07:14 PM | Mid | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $2,104,745,000 +52.7% | Assets $2,951,013,000 | EPS $3.72 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 2/11/2014 7:29:51 AM | View | Financials | Earnings | SEC | Y 2013 | Rev $610,412,000 +47.2% | Assets $2,951,013,000 | EPS $0.86 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 1/14/2014 10:20:04 AM | View | Financials | Earnings | SEC | Y 2013 | Rev $610,412,000 +47.2% | Assets $2,951,013,000 | EPS $0.86 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 11/5/2013 7:14:08 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $597,027,000 +39.6% | Assets $2,640,415,000 | EPS $1.25 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 11/5/2013 6:58:09 AM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $597,027,000 +39.6% | Assets $2,640,415,000 | EPS $1.25 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/6/2013 7:10:00 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $457,642,000 +50.3% | Assets $2,378,259,000 | EPS $0.79 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 8/6/2013 6:59:49 AM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $457,642,000 +50.3% | Assets $2,378,259,000 | EPS $0.79 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/3/2013 10:20:35 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $439,664,000 +89.7% | Assets $2,275,998,000 | EPS $0.90 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/3/2013 7:31:27 AM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $439,664,000 +89.7% | Assets $2,275,998,000 | EPS $0.90 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 4/26/2013 6:26:25 PM | View | Proxy | SEC | Y 2012 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 2/15/2013 4:13:21 PM | Mid | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $1,378,477,000 +209.2% | Assets $2,080,490,000 | EPS $6.75 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 2/14/2013 7:28:55 AM | View | Financials | Earnings | SEC | Y 2012 | Rev $414,602,000 +237.1% | Assets $2,080,490,000 | EPS $4.08 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 10/24/2012 7:29:40 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $427,687,000 +315.9% | Assets $1,660,615,000 | EPS $1.72 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 10/24/2012 7:14:08 AM | View | Financials | Earnings | SEC | 3Q 2012 | Rev $427,687,000 +315.9% | Assets $1,660,615,000 | EPS $1.72 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 7/25/2012 7:00:24 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $304,399,000 +182.3% | Assets $1,457,500,000 | EPS $0.70 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 7/25/2012 6:45:33 AM | View | Financials | Earnings | SEC | 2Q 2012 | Rev $304,399,000 +182.3% | Assets $1,457,500,000 | EPS $0.70 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 4/26/2012 2:13:34 PM | View | Proxy | SEC | Y 2011 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 4/26/2012 7:34:36 AM | View | Financials | Earnings | SEC | 1Q 2012 | Rev $231,789,000 +106.6% | Assets $1,350,159,000 | EPS $0.11 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 4/26/2012 7:31:17 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $231,789,000 +106.6% | Assets $1,350,159,000 | EPS $0.11 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 2/21/2012 7:31:08 AM | Mid | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $445,824,000 -2.9% | Assets $1,323,583,000 | EPS -$2.45 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 2/13/2012 7:11:15 AM | View | Financials | Earnings | SEC | Y 2011 | Rev $122,977,000 -8.0% | Assets $1,323,583,000 | EPS -$0.58 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 10/27/2011 2:12:47 PM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $102,833,000 -3.0% | Assets $983,031,000 | EPS -$0.68 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 10/27/2011 7:31:02 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $102,833,000 -3.0% | Assets $983,031,000 | EPS -$0.68 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 7/28/2011 7:30:53 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $107,810,000 -7.0% | Assets $1,046,864,000 | EPS -$0.69 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 7/28/2011 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $107,810,000 -7.0% | Assets $1,046,864,000 | EPS -$0.69 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/3/2011 7:30:45 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2011 ending: 3/31/2011 | Rev: $112,204,000 +8.4% | Assets $1,074,293,000 | EPS -$0.49 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 5/3/2011 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2011 | Rev $112,204,000 +8.4% | Assets $1,074,293,000 | EPS -$0.49 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 4/28/2011 12:23:11 PM | View | Proxy | SEC | Y 2010 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 2/18/2011 12:00:00 AM | View | Financials | Earnings | SEC | Y 2010 | Rev $133,675,000 +38.1% | Assets $1,089,432,000 | EPS -$0.16 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 2/17/2011 7:30:53 AM | Mid | View | Financials | 10-K | SEC | Y 2010 ending: 12/31/2010 | Rev: $459,074,000 +21.0% | Assets $1,089,432,000 | EPS -$1.26 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 10/28/2010 7:33:17 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2010 ending: 9/30/2010 | Rev: $105,979,000 -9.8% | Assets $942,433,000 | EPS -$0.41 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 10/28/2010 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $105,979,000 -9.8% | Assets $942,433,000 | EPS -$0.41 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 7/29/2010 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2010 | Rev $115,886,000 +28.7% | Assets $790,641,000 | EPS -$0.31 | Export Earnings Model | |
| REGENERON PHARMACEUTICALS INC (REGN) | 7/28/2010 7:30:36 AM | Small | View | Financials | 10-Q | SEC | 2Q 2010 ending: 6/30/2010 | Rev: $115,886,000 +28.7% | Assets $790,641,000 | EPS -$0.31 | |
| REGENERON PHARMACEUTICALS INC (REGN) | 4/29/2010 12:00:00 AM | View | Financials | Earnings | SEC | Y 2009 | Rev $96,800,000 | Assets $741,202,000 | Export Earnings Model | ||
| REGENERON PHARMACEUTICALS INC (REGN) | 4/26/2010 5:56:42 PM | View | Proxy | SEC | Y 2009 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 2/19/2010 12:00:00 AM | View | Financials | Earnings | SEC | Y 2009 | Rev $96,800,000 | Assets $741,202,000 | Export Earnings Model | ||
| REGENERON PHARMACEUTICALS INC (REGN) | 11/4/2009 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2009 | Rev $117,455,000 | Export Earnings Model | |||
| REGENERON PHARMACEUTICALS INC (REGN) | 8/4/2009 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2009 | Rev $90,032,000 | Export Earnings Model | |||
| REGENERON PHARMACEUTICALS INC (REGN) | 5/1/2009 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2009 | Export Earnings Model | ||||
| REGENERON PHARMACEUTICALS INC (REGN) | 4/24/2009 8:30:37 AM | View | Proxy | SEC | Y 2008 | ||||||
| REGENERON PHARMACEUTICALS INC (REGN) | 2/26/2009 12:00:00 AM | View | Financials | Earnings | SEC | Y 2008 | Export Earnings Model |